Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.07.02.21259939: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: Ethical approval was obtained for this study to be carried out through the NHS Lothian BioResource (SR1407) and London-Brent Research Ethics Committee (REC ref: 20/HRA/3764 IRAS:28653).
Consent: All recruits gave written and informed consent for serial blood sample collection.Sex as a biological variable The mean age of the participants was 44.5 years (21 – 65 y), with 72 female (71% of cohort) participants. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Serological assays: The Abbott SARS-CoV-2 IgG (NHS Lothian) and SARS-CoV-2 IgGII (NHS Greater Glasgow and Clyde) assays are … SciScore for 10.1101/2021.07.02.21259939: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: Ethical approval was obtained for this study to be carried out through the NHS Lothian BioResource (SR1407) and London-Brent Research Ethics Committee (REC ref: 20/HRA/3764 IRAS:28653).
Consent: All recruits gave written and informed consent for serial blood sample collection.Sex as a biological variable The mean age of the participants was 44.5 years (21 – 65 y), with 72 female (71% of cohort) participants. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Serological assays: The Abbott SARS-CoV-2 IgG (NHS Lothian) and SARS-CoV-2 IgGII (NHS Greater Glasgow and Clyde) assays are two-step chemiluminescent microparticle immunoassays (CMIA) designed to detect IgG antibodies against nucleoprotein and RBD respectively. SARS-CoV-2 IgGIIsuggested: None, DiaSorin LIASON trimericS IgG (NHS Highland) and Siemens sCOVG RBD IgG (NHS Tayside) assays are also two-step CMIA designed to detect IgG antibodies. DiaSorin LIASON trimericS IgGsuggested: Nonedetect IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources Briefly, 293Tcells were transfected with pNL4-3ΔEnv-nanoluc and pSARS-CoV-2-SΔ19. 293Tcellssuggested: NoneThe mixture was subsequently added to 293TAce2 cl22 cells (for analyses using SARS-CoV-2 Wuhan-Hu-1 pseudovirus) or HT1080Ace2 cl14 cells (for analyses involving variant pseudovirus panels and respective Wuhan-Hu-1 R683G controls). HT1080Ace2 cl14suggested: NoneRecombinant DNA Sentences Resources Briefly, 293Tcells were transfected with pNL4-3ΔEnv-nanoluc and pSARS-CoV-2-SΔ19. pNL4-3ΔEnv-nanolucsuggested: NonepSARS-CoV-2-SΔ19suggested: NoneSoftware and Algorithms Sentences Resources The half-maximal neutralization titers for sera (NT50) were determined using four-parameter nonlinear regression (least squares regression method without weighting; constraints: top=1, bottom=0) (GraphPad Prism). GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-